Skip to Content

Captique FDA Approval History

FDA Approved: Yes (First approved November 12, 2004)
Brand name: Captique
Generic name: dermal filler
Dosage form: Injectable Gel
Company: Inamed Corp / Genzyme Corp
Treatment for: Wrinkle Correction

Captique is a non-animal stabilized hyaluronic acid dermal filler indicated for the correction of moderate to severe facial wrinkles.

Development Timeline for Captique

DateArticle
Dec  2, 2004Approval Captique Inamed Corp / Genzyme Corp - Treatment for Facial Wrinkle Correction

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.